FLJ46838 inhibitors are a class of chemical compounds that specifically interact with and inhibit the activity of the FLJ46838 protein, a target identified in various molecular and biochemical pathways. These inhibitors are typically designed to bind to the active or regulatory sites of the protein, preventing its normal function and modulating associated cellular processes. FLJ46838, often characterized as a signaling protein, plays a critical role in cellular regulation, and its inhibition can affect downstream pathways that influence cellular growth, division, and communication. FLJ46838 inhibitors are structurally diverse, with some belonging to small molecules while others may include more complex molecules such as peptides or larger macromolecules. The structural specificity of these inhibitors is essential for ensuring that they effectively interact with FLJ46838 without off-target effects on other proteins or cellular machinery.
The design and optimization of FLJ46838 inhibitors generally rely on high-throughput screening, structure-activity relationship (SAR) studies, and molecular docking approaches to improve binding affinity and selectivity. These compounds are often tested in vitro using biochemical assays to measure their inhibitory potency against FLJ46838 and to characterize their mechanism of action. Researchers frequently employ crystallographic techniques or computational modeling to visualize how these inhibitors bind to the FLJ46838 protein and to further refine their structure for enhanced inhibition. Understanding the molecular interactions between FLJ46838 and its inhibitors allows for greater insights into the protein's function in biological systems and can guide the development of more potent and selective inhibitors for further biochemical study.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, potentially affecting proteins involved in signal transduction pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, potentially altering downstream proteins related to cellular growth signals. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase inhibitor, altering chromatin structure and gene expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor, leading to changes in DNA methylation and gene expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
Proteasome inhibitor, could affect protein degradation pathways involving FLJ46838. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Promotes apoptosis, potentially influencing proteins that regulate cell death. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor, affecting cell growth and protein synthesis pathways. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits eukaryotic protein synthesis, possibly affecting the stability of FLJ46838. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, possibly impacting proteins in the MAPK signaling pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor, potentially influencing stress response proteins. | ||||||